In the first sham-controlled trial of HBOT for combat PTSD, 60 daily sessions cut veterans’ PTSD symptom scores about 40% while the sham group’s scores worsened (Doenyas-Barak, 2024, N=56). The VA does not cover hyperbaric oxygen therapy for TBI or PTSD, so most veterans pay $6,000 to $12,000 out of pocket or access nonprofit-funded and clinical-trial care.
The U.S. military and VA have funded multiple clinical trials testing HBOT for blast-related traumatic brain injury and PTSD, the signature wounds of modern warfare that often resist standard treatment. The results are genuinely encouraging for PTSD and mixed for TBI. This is an honest account of what the trials show, what the VA will and will not pay for, and how veterans actually access treatment.
What does blast TBI do to the brain?
Blast injury damages the brain through a pressure wave rather than a direct impact. An improvised explosive device (IED) sends a rapid pressure wave through the skull that produces diffuse axonal injury and microvascular damage spread through the white matter. That mechanism differs biologically from civilian TBI such as sports concussion, falls, and car accidents.
The resulting symptoms, often called invisible wounds, include headaches, cognitive dysfunction, memory problems, irritability, sleep disruption, and sensory sensitivities. Many veterans with blast-related TBI also carry PTSD, and the two conditions are clinically difficult to separate: both involve autonomic nervous system dysregulation and measurable changes on brain imaging. HBOT’s proposed neurobiological effects, including reduced neuroinflammation, angiogenesis, and support for neuroplasticity, are theoretically relevant to both. The brain injury and HBOT article covers the broader neurological picture.
Does HBOT work for veterans with PTSD?
PTSD is where the veteran HBOT evidence is strongest. The most rigorous study is a 2024 randomized, sham-controlled trial of 56 combat veterans with treatment-resistant PTSD. Veterans received 60 daily sessions at 2.0 ATA (90 minutes, 100% oxygen with air breaks) or a sham at 1.02 ATA room air.
The HBOT group’s CAPS-5 scores fell from 42.57 to 25.8 (P < 0.001), while the sham group’s scores rose from 45.11 to 47.75. Brain imaging showed improved functional connectivity in the default-mode, central-executive, and salience networks. The fact that the sham group got worse, rather than simply failing to improve, is the strongest available argument against a placebo explanation. An earlier 2022 randomized controlled trial by the same group in 35 veterans reported a large effect on PTSD symptoms (effect size 1.64) alongside MRI changes in fronto-limbic white matter and the fornix.
Veteran HBOT trials for PTSD and blast TBI
| Study | Design | N | Pressure | Result |
|---|---|---|---|---|
| Doenyas-Barak 2024 | Sham-controlled RCT | 56 | 2.0 ATA | CAPS-5 42.6 to 25.8; sham group worsened |
| Doenyas-Barak 2022 | RCT | 35 | 2.0 ATA | Effect size 1.64; white-matter changes |
| Harch 2012 | Phase I, uncontrolled | 16 | 1.5 ATA | +14.8 IQ points; no control group |
| Weaver 2018 (BIMA) | Sham-controlled RCT | 71 | 1.5 ATA | Benefit not sustained past 6 months |
HBOT is not a cure for PTSD and does not replace evidence-based trauma therapy. The HBOT for PTSD and mental health and HBOT articles cover the psychological-care dimension that any responsible protocol pairs with treatment.
Does HBOT help veterans with TBI or post-concussion syndrome?
The TBI picture is more mixed than the PTSD picture. A 2012 Phase I study by Harch and colleagues of 16 military subjects with blast-induced post-concussion syndrome found that 40 sessions at 1.5 ATA produced a 14.8-point average increase in full-scale IQ, with reductions in PTSD symptoms, depression, and suicidal ideation, and SPECT imaging normalizing in most previously abnormal areas. That study had no control group.
A larger VA-funded sham-controlled trial (BIMA, Weaver et al., 2018) of 71 service members found HBOT improved post-concussion symptoms compared to sham at the end of treatment, but the benefit did not persist beyond 6 months. Both groups improved, which raises the question of whether the 1.5 ATA sham was truly inert. A separate 2013 randomized trial (Boussi-Gross et al.) reported improvement in post-concussion symptoms years after mild TBI, again with the sham-design caveats that run through this field. Designing a true placebo for HBOT is genuinely hard, because pressure itself has physiological effects and patients in any arm still receive structured clinical attention. The HBOT and TBI data article breaks down the concussion trials in more depth.
Does the VA cover HBOT for TBI or PTSD?
The VA does not cover HBOT for TBI or PTSD. It covers hyperbaric oxygen for the same approved indications as Medicare (wound healing, air embolism, carbon monoxide poisoning, radiation injury, and similar), which do not include TBI or PTSD. Veterans pursuing HBOT for these conditions pay out of pocket, enroll in clinical trials, or access subsidized care through nonprofits. A number of states have funded HBOT pilot programs for veterans with TBI or PTSD.
Nonprofit organizations and veteran service organizations fund HBOT access for some veterans, and connecting with them before paying full private rates is worth the effort. The insurance coverage guide explains the off-label landscape, and the cost guide lays out what private treatment involves financially.
What should veterans know before pursuing HBOT?
Protocols used in veteran TBI and PTSD research have typically run 1.5 to 2.0 ATA at 100% oxygen for 40 to 60 sessions of 60 to 90 minutes each in a hard chamber. Some researchers find 1.5 ATA adequate for TBI while the PTSD data favors 2.0 ATA. There is no established consensus protocol for this off-label application, and HBOT works best as one part of a comprehensive plan that includes psychological care, rehabilitation, and sleep support.
Claustrophobia deserves specific attention, since enclosed spaces can be difficult for veterans with a trauma history. The session guide explains what each visit involves, and the side effects guide covers what to watch for during treatment.
Frequently Asked Questions
Can HBOT cure PTSD?
No. HBOT is not a cure for PTSD. The 2024 sham-controlled trial by Doenyas-Barak and colleagues found it reduced PTSD symptom scores in treatment-resistant combat veterans, but psychological trauma still requires psychological treatment. HBOT is not a substitute for evidence-based PTSD therapies such as EMDR, prolonged exposure, or cognitive processing therapy, and the strongest results came when it was added to structured clinical care.
How is blast TBI different from sports concussion?
Blast injury damages the brain through a pressure wave, producing more diffuse microvascular and axonal damage spread through the white matter, rather than a single focal impact. Whether this makes veterans more or less likely to respond to HBOT than sports concussion patients is unknown, because the research populations differ and direct comparisons have not been done.
Are there HBOT programs specifically for veterans?
Yes. Because the VA does not cover HBOT for TBI or PTSD, several nonprofit organizations and veteran service organizations provide subsidized or free treatment, and some states have funded pilot programs. Enrolling in a registered clinical trial is another route to access. Checking these options before paying full private rates of $6,000 to $12,000 is worthwhile.
Is HBOT safe for veterans with claustrophobia related to trauma?
Claustrophobia is a real consideration. Many hyperbaric facilities accommodate anxious patients through gradual acclimatization, open communication throughout the session, and in some cases mild anxiolytics. Multiplace chambers, which are larger multi-patient rooms, are less confining than monoplace chambers and may be easier for some veterans to tolerate.
Sources
- Doenyas-Barak K, Kutz I, Lang E, et al. “Hyperbaric Oxygen Therapy for Veterans With Combat-Associated Posttraumatic Stress Disorder: A Randomized, Sham-Controlled Clinical Trial.” Journal of Clinical Psychiatry, 2024. doi.org/10.4088/jcp.24m15464
- Doenyas-Barak K, et al. “Hyperbaric oxygen therapy improves symptoms, brain’s microstructure and functionality in veterans with treatment resistant PTSD: A prospective, randomized, controlled trial.” PLOS ONE, 2022. doi.org/10.1371/journal.pone.0264161
- Harch PG, et al. “A Phase I Study of Low-Pressure Hyperbaric Oxygen Therapy for Blast-Induced Post-Concussion Syndrome and PTSD.” Journal of Neurotrauma, 2012. doi.org/10.1089/neu.2011.1895
- Weaver LK, et al. “Hyperbaric oxygen for post-concussive symptoms in United States military service members: a randomized clinical trial (BIMA).” Undersea and Hyperbaric Medicine, 2018. doi.org/10.22462/03.04.2018.1
- Boussi-Gross R, et al. “Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury: randomized prospective trial.” PLoS ONE, 2013. PMID 24260334
- Harch PG, et al. “Case control study: Hyperbaric oxygen treatment of mild traumatic brain injury persistent post-concussion syndrome and PTSD.” Medical Gas Research, 2017. doi.org/10.4103/2045-9912.215745
- Undersea and Hyperbaric Medical Society. “Indications for Hyperbaric Oxygen Therapy.” uhms.org
- U.S. Department of Veterans Affairs. “VA Research on PTSD.” research.va.gov
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
